AngioSculpt Scoring Balloon Catheter Gets PMA For Coronary Artery Disease
This article was originally published in The Gray Sheet
Executive Summary
AngioScore may become an acquisition target for a larger interventional cardiology company following the Jan. 8 FDA approval of its AngioSculpt scoring balloon catheter to treat coronary artery stenosis